NovaPoint Capital LLC Raises Holdings in The Procter & Gamble Company (NYSE:PG)

NovaPoint Capital LLC increased its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 3.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,351 shares of the company’s stock after buying an additional 687 shares during the period. Procter & Gamble comprises approximately 1.3% of NovaPoint Capital LLC’s investment portfolio, making the stock its 25th biggest holding. NovaPoint Capital LLC’s holdings in Procter & Gamble were worth $4,044,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Chronos Wealth Management LLC grew its stake in Procter & Gamble by 2.1% in the third quarter. Chronos Wealth Management LLC now owns 34,823 shares of the company’s stock valued at $6,031,000 after purchasing an additional 704 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Procter & Gamble by 20.8% in the 3rd quarter. Blue Trust Inc. now owns 76,118 shares of the company’s stock valued at $12,553,000 after buying an additional 13,081 shares in the last quarter. IFG Advisors LLC grew its position in shares of Procter & Gamble by 6.7% in the 3rd quarter. IFG Advisors LLC now owns 2,218 shares of the company’s stock worth $384,000 after buying an additional 139 shares during the last quarter. West Oak Capital LLC raised its stake in shares of Procter & Gamble by 0.4% during the 3rd quarter. West Oak Capital LLC now owns 16,964 shares of the company’s stock worth $2,938,000 after acquiring an additional 75 shares in the last quarter. Finally, Moss Adams Wealth Advisors LLC lifted its position in Procter & Gamble by 6.3% during the third quarter. Moss Adams Wealth Advisors LLC now owns 6,618 shares of the company’s stock valued at $1,146,000 after acquiring an additional 393 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Susan Street Whaley sold 450 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the transaction, the insider now owns 13,072 shares in the company, valued at $2,212,043.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock valued at $65,140,718 in the last three months. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Price Performance

NYSE:PG opened at $171.28 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The company has a 50 day moving average price of $171.77 and a 200-day moving average price of $167.11. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The firm has a market cap of $404.23 billion, a price-to-earnings ratio of 28.45, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the company earned $1.83 earnings per share. The firm’s revenue for the quarter was down .6% on a year-over-year basis. Equities research analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 66.94%.

Analyst Upgrades and Downgrades

PG has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price target on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Citigroup boosted their price target on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $159.00 price objective on shares of Procter & Gamble in a research report on Tuesday. Nine equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $176.21.

Check Out Our Latest Stock Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.